SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-049277
Filing Date
2022-04-25
Accepted
2022-04-25 08:01:07
Documents
13
Period of Report
2022-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213321d1_8k.htm   iXBRL 8-K 25346
2 EXHIBIT 99.1 tm2213321d1_ex99-1.htm EX-99.1 11771
  Complete submission text file 0001104659-22-049277.txt   215251

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aytu-20220425.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20220425_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20220425_pre.xml EX-101.PRE 22593
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2213321d1_8k_htm.xml XML 3607
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 22847361
SIC: 2834 Pharmaceutical Preparations